Fett J W, Strydom D J, Lobb R R, Alderman E M, Bethune J L, Riordan J F, Vallee B L
Biochemistry. 1985 Sep 24;24(20):5480-6. doi: 10.1021/bi00341a030.
The first human tumor derived protein with in vivo angiogenic activity to be obtained in pure form has been isolated from serum-free supernatants of an established human adenocarcinoma cell line (HT-29) and named angiogenin. It was purified by cation-exchange and reversed-phase high-performance liquid chromatography; the yield was approximately 0.5 microgram/L of medium. Biological activity of angiogenin was monitored throughout purification by using the chick embryo chorioallantoic membrane assay. Statistical evaluation demonstrates that it displays activity in this system with as little as 35 fmol per egg. Moreover, only 3.5 pmol is required to induce extensive blood vessel growth in the rabbit cornea. The amino acid composition of this basic (isoelectric point greater than 9.5), single-chain protein of molecular weight approximately 14 400 has been determined. The amino terminus is blocked, and the carboxyl-terminal residue is proline.
首个以纯形式获得的具有体内血管生成活性的人类肿瘤衍生蛋白,是从一个已建立的人类腺癌细胞系(HT - 29)的无血清上清液中分离出来的,并被命名为血管生成素。它通过阳离子交换和反相高效液相色谱法进行纯化;产量约为每升培养基0.5微克。在整个纯化过程中,通过使用鸡胚绒毛尿囊膜试验监测血管生成素的生物活性。统计评估表明,它在该系统中每枚鸡蛋只需35飞摩尔就能显示出活性。此外,在兔角膜中诱导广泛血管生长仅需3.5皮摩尔。已确定这种碱性(等电点大于9.5)、分子量约为14400的单链蛋白的氨基酸组成。氨基末端被封闭,羧基末端残基是脯氨酸。